medline.ch Neurologie Alzheimer

	Statistical inference for saved time based on disease progression curves in Alzheimer's disease research. Contemp Clin Trials Commun Shan G, Zhang Y, Ding AA. PMID: 42436821 [PubMed]
	Bioinformatic analysis of differentially expressed mitochondrion-related genes, immune cell infiltration, and diagnostic value in Alzheimer's disease. BMC Neurol Tang L, Wu N, Zhu Y, Xu H, Mo Y. PMID: 42436416 [PubMed - as supplied by publisher]
	Passive early screening for Alzheimer's disease and related dementias using EHR comorbidity patterns. NPJ Digit Med Onishchenko D, Mastrianni JA, Chattopadhyay I. PMID: 42436226 [PubMed - as supplied by publisher]
	Targeting the APOE4-driven peripheral-central immune axis: a new frontier for Alzheimer's disease therapy. Pharmacol Res Shang Y, Zhai Z, Cong L, Dong X. PMID: 42435996 [PubMed - as supplied by publisher]
	CSF and plasma tau biomarkers in the Down syndrome-Alzheimer's disease continuum. EBioMedicine Arranz J, Lantero-Rodríguez J, Braun-Wohlfahrt LS, Vaqué-Alcázar L, Rodríguez-Baz Í, Kac PR, Arslan B, Maure-Blesa L, Pertierra L, Videla L, Carmona-Iragui M, Benejam B, Del Hoyo Soriano L, Barroeta I, Fernández S, Bejanin A, Lleó A, Ashton NJ, Zetterberg H, Fortea J, Alcolea D, Montoliu-Gaya L. PMID: 42435584 [PubMed - as supplied by publisher]
	Exploring thiazole conjugates as cholinesterase inhibitors for Alzheimer's disease treatment. Future Med Chem Dabas A, Yadav P, Singh R. PMID: 42435043 [PubMed - as supplied by publisher]
	Multidomain cognitive impairment, along with comorbidities and psychiatric hospitalizations, shorten survival time of patients with Alzheimer's disease dementia: A long term, naturalistic follow-up study. J Alzheimers Dis Doganyigit B, Schurr T, Hofer A, Schütz S, Defrancesco M. PMID: 42434908 [PubMed - as supplied by publisher]
	Mitophagy deficiency and calcium dyshomeostasis underlying the pathogenesis and progression of Alzheimer's disease. J Alzheimers Dis Meng G, Cai L, Mo Z, An S, Sun W, Shen P, Xie Y. PMID: 42434902 [PubMed - as supplied by publisher]
	A real-world feasibility study: at home longitudinal use of the Cumulus NeuLogiqÂ® platform for electrophysiological and neurocognitive measures in patients with mild Alzheimer's Disease dementia. Front Digit Health Diggin S, Rueda-Delgado L, Buick A, Dyer JF, Alexander-Sefre A, Barbey F, Rowe JB, Muhammed K, Harel BT, Hansen BJ, Tunbridge E, Lai R, Hawellek DJ, Hake AM, Marston H, Oswal A, Coulthard E, Pattan V, Evans V, Gibson S, Kipps C, Kozak R, Mannering N, Moss M, Nguyen V, Ruddock K, Shinobu LA, Toniolo S, Murphy B. PMID: 42434375 [PubMed]
	Region-specific Transcriptomic Signatures in Alzheimer's Disease: A Meta-analysis of Vulnerable Brain Regions Reveals MicroRNA-hub Gene Regulatory Networks. J Med Signals Sens Jaberi KR, Alashti SK, Hooshmandi S, Vatankhah P, Haghighi MR, Savardashtaki A, Aligholi H, Jaberi AR. PMID: 42434351 [PubMed]
	Increased Risk of Alzheimer Disease-Associated Mortality in Nonobese vs Obese Metabolic Dysfunction-Associated Steatotic Liver Disease: A 30-Year National Cohort Study. Gastro Hep Adv Boateng S, Nguefang GL, Mapouka M, Lawal R, Gyabaah S, Nwatamole B, Kasar A, Adatsi S, Njei B. PMID: 42434322 [PubMed]
	Efficacy and predictors of cognitive stimulation therapy combined with pharmacotherapy for mild-to-moderate Alzheimer's disease: a randomized controlled trial. Front Psychiatry Cai L, Zhao X, Liao C, Liu Q, Hu S, Huang M. PMID: 42433215 [PubMed]
	Reshaping the immune landscape: next-generation microglia-targeted therapies for Alzheimer's disease. Biol Res Wu J, Zhao J, Chen S, Xu F. PMID: 42432729 [PubMed - as supplied by publisher]
	Microglial synaptic pruning in early Alzheimer's disease: emerging roles of the IL-1Î²-NLRP3 axis. Inflammopharmacology Kaushik AS, Singh N. PMID: 42432341 [PubMed - as supplied by publisher]
	Repurposing apremilast for alzheimer's disease: multitarget modulation of cAMPâ€‘PI3K/Akt-GSKâ€‘3Î² and NFâ€‘ÎºB signaling. Metab Brain Dis Choudhary N, Rana S, Vashisht K, Sharma V, Bhatia V, Ashawat MS, Kushawaha SK. PMID: 42432263 [PubMed - indexed for MEDLINE]
	An interpretable multimodal framework using compact biomarkers and Kolmogorov-Arnold networks improves the early diagnosis of Alzheimer's disease. Sci Rep Tan D, Song L, Tang Y, Han A. PMID: 42431966 [PubMed - as supplied by publisher]
	Novel approach to early prediction of alzheimer's disease progression using integrated deep regulatory genetic neural network and optimized deep belief networks. Sci Rep Roobini S, Kavitha MS, Karthik S. PMID: 42431913 [PubMed - as supplied by publisher]
	Can we identify people with Alzheimer's disease from examination of the eye? A bidirectional Mendelian randomization (MR) study. J Prev Alzheimers Dis Kiser H, Budu-Aggrey A, Bailey JNC, Villaplana-Velasco A, Bernabeu MO, Jiang X, Owen CG, Haines JL, Pasquale LR, MacGregor S, Gao XR, Wiggs JL, Jiang C, Choquet H, NEIGHBORHOOD consortium, International Glaucoma Genetics Consortium, UK Biobank Eye and Vision Consortium, Smith GD, Kehoe PG, Davies NM, Hanson AL, Anderson EL, Atan D. PMID: 42430965 [PubMed - as supplied by publisher]
	Suboptimal adherence to brain health recommendations in patients pursuing anti-amyloid antibody therapy for Alzheimer's disease: Report from the Brain Health Vital Signs project. J Prev Alzheimers Dis Daffner KR, Riera K, Ghorayeb GR, McFeeley BM, Weizenbaum E, Willment K, Gale SA. PMID: 42430964 [PubMed - as supplied by publisher]
	NavegApp, a serious game for assessing spatial cognition: Diagnostic accuracy in preclinical and prodromal Alzheimer's disease. PLOS Digit Health Sánchez-Escudero JP, Díaz González DC, Aguillón-Niño DF, Garcia-Barrera MA, Aguirre-Acevedo DC, Trujillo-Orrego N. PMID: 42430332 [PubMed]

Artikel 1 - 20 / 71334

Seite 1 von 3567

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung